THOMAS C. FREYMAN - 09 May 2025 Form 4 Insider Report for AbbVie Inc. (ABBV)

Role
Director
Signature
/s/ T.O. Odutayo, attorney-in-fact for Thomas C. Freyman
Issuer symbol
ABBV
Transactions as of
09 May 2025
Net transactions value
$0
Form type
4
Filing time
13 May 2025, 17:05:26 UTC
Previous filing
07 May 2024
SEC
View on sec.gov

Reporting Owners (1)

Name Relationship Address Signature Signature date CIK
FREYMAN THOMAS C Director 1 N. WAUKEGAN ROAD, NORTH CHICAGO /s/ T.O. Odutayo, attorney-in-fact for Thomas C. Freyman 13 May 2025 0001239126

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction ABBV Common Stock, $0.01 par value Award $0 +1,203 +0.96% $0.000000 126,751 09 May 2025 Direct F1
holding ABBV Common Stock, $0.01 par value 4,000 09 May 2025 By spouse in trust F2
holding ABBV Common Stock, $0.01 par value 1,941 09 May 2025 By spouse in trust for son F3
holding ABBV Common Stock, $0.01 par value 1,941 09 May 2025 By spouse in trust for son F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 These are restricted stock units awarded under the AbbVie Amended and Restated 2013 Incentive Stock Program (the "Program"). They will be paid, on a one-to-one basis, in shares of AbbVie common stock on the earlier of the date of the director's separation from service, death, or the occurrence of a change in control (as defined in the Program).
F2 The reporting person's spouse is the trustee of the trust. The trust is revocable by his spouse. The reporting person disclaims beneficial ownership of these securities.
F3 Shares are held in an irrevocable trust for the benefit of the reporting person's son. The reporting person's spouse is the trustee of the trust. The reporting person disclaims beneficial ownership of these securities.